Allergan plc Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan plc for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 02 2019 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 17,080 | 15 K to 17.1 K (+13.75 %) |
| May 02 2019 | AGN | Allergan plc | COUGHLIN CHRISTOPHER J | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 15,016 | 16 K to 15 K (-5.97 %) |
| May 02 2019 | AGN | Allergan plc | McDonnell Peter J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 7,343 | 5.3 K to 7.3 K (+39.10 %) |
| May 02 2019 | AGN | Allergan plc | McDonnell Peter J | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 5,279 | 6.2 K to 5.3 K (-15.29 %) |
| May 02 2019 | AGN | Allergan plc | KLEMA CATHY | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 25,081 | 26 K to 25.1 K (-3.66 %) |
| May 02 2019 | AGN | Allergan plc | McDonnell Peter J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 7,343 | 5.3 K to 7.3 K (+39.10 %) |
| May 02 2019 | AGN | Allergan plc | McDonnell Peter J | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 5,279 | 6.2 K to 5.3 K (-15.29 %) |
| May 02 2019 | AGN | Allergan plc | KLEMA CATHY | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 25,081 | 26 K to 25.1 K (-3.66 %) |
| May 02 2019 | AGN | Allergan plc | HUGIN ROBERT J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 5,285 | 3.2 K to 5.3 K (+64.08 %) |
| May 02 2019 | AGN | Allergan plc | HUGIN ROBERT J | Director | Payment of Exercise | F | 147.00 | 205 | 30,135 | 3,221 | 3.4 K to 3.2 K (-5.98 %) |
| May 02 2019 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Grant | A | 145.33 | 2,064 | 299,961 | 2,684 | 620 to 2.7 K (+332.90 %) |
| May 02 2019 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Payment of Exercise | F | 147.00 | 574 | 84,378 | 620 | 1.2 K to 620 (-48.07 %) |
| May 02 2019 | AGN | Allergan plc | HUGIN ROBERT J | Director | Grant | A | 145.33 | 2,064 | 299,961 | 5,285 | 3.2 K to 5.3 K (+64.08 %) |
| May 02 2019 | AGN | Allergan plc | HUGIN ROBERT J | Director | Payment of Exercise | F | 147.00 | 205 | 30,135 | 3,221 | 3.4 K to 3.2 K (-5.98 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
| May 02 2019 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Grant | A | 145.33 | 2,064 | 299,961 | 2,684 | 620 to 2.7 K (+332.90 %) |
| May 02 2019 | AGN | Allergan plc | Greenberg Michael Eldon | Director | Payment of Exercise | F | 147.00 | 574 | 84,378 | 620 | 1.2 K to 620 (-48.07 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,974 | 1.9 K to 4 K (+108.06 %) |
| May 02 2019 | AGN | Allergan plc | FREYMAN THOMAS C | Director | Payment of Exercise | F | 147.00 | 748 | 109,956 | 1,910 | 2.7 K to 1.9 K (-28.14 %) |
| May 02 2019 | AGN | Allergan plc | Brown Adriane M | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,907 | 1.8 K to 3.9 K (+111.99 %) |
| May 02 2019 | AGN | Allergan plc | Brown Adriane M | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 1,843 | 2.8 K to 1.8 K (-34.08 %) |
| May 02 2019 | AGN | Allergan plc | Boccuzi Joseph H | Director | Grant | A | 145.33 | 2,064 | 299,961 | 4,596 | 2.5 K to 4.6 K (+81.52 %) |
| May 02 2019 | AGN | Allergan plc | Boccuzi Joseph H | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 2,532 | 3.5 K to 2.5 K (-27.35 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 145.33 | 2,064 | 299,961 | 8,207 | 6.1 K to 8.2 K (+33.60 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 6,143 | 7.1 K to 6.1 K (-13.43 %) |
| May 02 2019 | AGN | Allergan plc | Brown Adriane M | Director | Grant | A | 145.33 | 2,064 | 299,961 | 3,907 | 1.8 K to 3.9 K (+111.99 %) |
| May 02 2019 | AGN | Allergan plc | Brown Adriane M | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 1,843 | 2.8 K to 1.8 K (-34.08 %) |
| May 02 2019 | AGN | Allergan plc | Boccuzi Joseph H | Director | Grant | A | 145.33 | 2,064 | 299,961 | 4,596 | 2.5 K to 4.6 K (+81.52 %) |
| May 02 2019 | AGN | Allergan plc | Boccuzi Joseph H | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 2,532 | 3.5 K to 2.5 K (-27.35 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 145.33 | 2,064 | 299,961 | 8,207 | 6.1 K to 8.2 K (+33.60 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 6,143 | 7.1 K to 6.1 K (-13.43 %) |